Here's the live share price of Anthem Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences | -2.98 | 13.72 | 17.50 | -4.59 | -1.06 | -0.35 | -0.21 |
| Sun Pharmaceutical Industries | 1.24 | -6.71 | 0.10 | -0.23 | -4.33 | 18.85 | 21.21 |
| Divi's Laboratories | 1.82 | 2.39 | 1.45 | -5.86 | 10.50 | 25.36 | 10.37 |
| Torrent Pharmaceuticals | 0.76 | -2.72 | 2.40 | 17.05 | 28.70 | 38.21 | 26.41 |
| Lupin | -0.48 | 1.01 | 6.57 | 19.73 | 19.86 | 52.24 | 16.94 |
| Dr. Reddy's Laboratories | 0.57 | -3.44 | 6.22 | -1.35 | 6.47 | 8.49 | 4.50 |
| Cipla | 0.71 | -3.37 | -10.99 | -21.52 | -18.29 | 10.94 | 5.52 |
| Zydus Lifesciences | 2.96 | 5.92 | 6.97 | -4.53 | 13.37 | 23.38 | 12.32 |
| Mankind Pharma | 2.18 | 2.74 | 0.29 | -14.29 | -17.76 | 14.26 | 8.32 |
| Aurobindo Pharma | 2.55 | 7.54 | 18.61 | 25.69 | 18.13 | 35.34 | 7.47 |
| Alkem Laboratories | 2.11 | 4.14 | -3.25 | -0.48 | 12.20 | 18.60 | 15.13 |
| Glenmark Pharmaceuticals | 3.81 | 4.56 | 12.79 | 20.63 | 67.35 | 66.08 | 31.14 |
| Laurus Labs | 3.38 | 17.22 | 6.82 | 26.15 | 80.92 | 55.00 | 20.83 |
| Biocon | 2.70 | -5.24 | -4.79 | 0.55 | 8.09 | 16.94 | -2.51 |
| Abbott India | 0.17 | -2.45 | -7.05 | -13.39 | -15.86 | 4.63 | 11.92 |
| GlaxoSmithKline Pharmaceuticals | 2.45 | 0.75 | 5.25 | -10.56 | -15.72 | 25.16 | 11.47 |
| Ipca Laboratories | 1.19 | -5.98 | -0.98 | 14.55 | 5.26 | 21.83 | 6.28 |
| Ajanta Pharma | -0.48 | -7.64 | 3.80 | 14.42 | 3.53 | 30.04 | 19.31 |
| J B Chemicals & Pharmaceuticals | -0.47 | -5.18 | 3.42 | 17.78 | 21.22 | 23.04 | 25.85 |
| Emcure Pharmaceuticals | 4.99 | 11.32 | 8.55 | 24.93 | 53.54 | 7.34 | 4.34 |
Over the last one year, Anthem Biosciences has declined 1.06% compared to peers like Sun Pharmaceutical Industries (-4.33%), Divi's Laboratories (10.50%), Torrent Pharmaceuticals (28.70%). From a 5 year perspective, Anthem Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (21.21%) and Divi's Laboratories (10.37%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 722.82 | 720.55 |
| 10 | 692.92 | 705.26 |
| 20 | 668.54 | 687.72 |
| 50 | 666.52 | 672.07 |
| 100 | 654.96 | 680.25 |
| 200 | 639.92 | 0 |
In the latest quarter, Anthem Biosciences remained same as its previous close in promoter holding, while DII stake increased to 7.60%, FII holding fell to 1.37%, and public shareholding moved down to 16.34% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 75,75,000 | 0.54 | 497.11 | |
| 50,77,076 | 4.76 | 333.18 | |
| 36,82,926 | 0.94 | 241.69 | |
| 32,40,200 | 1.03 | 212.64 | |
| 30,89,694 | 1.79 | 202.76 | |
| 25,21,979 | 0.72 | 165.5 | |
| 24,28,783 | 0.55 | 159.39 | |
| 23,61,990 | 2.91 | 155.01 | |
| 19,61,996 | 3.17 | 128.76 | |
| 15,38,749 | 1.09 | 100.98 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Apr 07, 2026, 12:09 AM IST IST | Anthem Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 14, 2026, 12:05 AM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Cessation |
| Feb 09, 2026, 10:02 PM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Feb 06, 2026, 01:09 AM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) |
| Feb 05, 2026, 11:33 PM IST IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Anthem Biosciences Ltd. is a Public Limited Listed company incorporated on 13/06/2006 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is U24233KA2006PLC039703 and registration number is 039703. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 1840.65 Cr. and Equity Capital is Rs. 111.82 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Anthem Biosciences is ₹722.60 as on Apr 17, 2026.
The Anthem Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
The market cap of Anthem Biosciences is ₹40,589.44 Cr as on Apr 17, 2026.
Today’s highest and lowest price of Anthem Biosciences are ₹734.35 and ₹715.30.
The 52-week high/low is the highest and lowest price at which Anthem Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Anthem Biosciences is ₹873.25 and 52-week low of Anthem Biosciences is ₹579.45 as on Apr 17, 2026.
The Anthem Biosciences has shown returns of -0.01% over the past day, 13.72% for the past month, 17.5% over 3 months, -1.06% over 1 year, -0.35% across 3 years, and -0.21% over 5 years.
P/E ratio of and PB ratio of Anthem Biosciences are 83.75 and 14.27 on Apr 17, 2026. While the company gives a dividend yield of 0.00 per annum.